Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03803553
Title Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

colon adenocarcinoma

Therapies

Binimetinib + Cetuximab + Encorafenib

Nivolumab

Fluorouracil + Irinotecan + Leucovorin

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST